Sign In
Buy LLY
$1,185.71
-6.23 (-0.523%)
At Close: Aug 07, 2026
S&P 500 Gains and Losses Today: Chip Stocks Help Lift the Tech Sector
04:45pm, Monday, 14'th Aug 2023
The S&P 500 rose 0.6% on Monday, Aug. 14, 2023, while the Dow and Nasdaq gained as well, as semiconductor stocks boosted the indexes.
Eli Lilly Shares Reach Record High After Completing Two Acquisitions
04:40pm, Monday, 14'th Aug 2023
Eli Lilly shares hit an all-time high as the drugmaker closed two acquisitions, including one related to the hot market for weight-loss treatments.
Prescribing Profits: 3 Stocks to Ride the Healthcare Relative Strength
04:09pm, Monday, 14'th Aug 2023
After a couple of weeks where the broad market experienced some weakness, the healthcare sector is showing considerable resiliency. Over the last month, the Healthcare Select Sector ETF XLV has be
What pharma brands will be impacted by Medicare price negotiations
02:59pm, Monday, 14'th Aug 2023
Jared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.
Eli Lilly Q2: Dividends Don't Lie
02:43pm, Monday, 14'th Aug 2023
Eli Lilly and Company reported a superb Q2, triggering a sharp price rally and pushing its valuation to a very concerning level in my view. There are certainly plenty to be optimistic about, ranging f
Eli Lilly notches best week on record: how to trade the run
06:09pm, Friday, 11'th Aug 2023
The 'Fast Money' traders talk Eli Lilly's stellar trading week and how to play the stock moving forward.
The Score: Eli Lilly, WeWork, Walt Disney and More Stocks That Defined the Week
05:37pm, Friday, 11'th Aug 2023
Here are some of the major companies whose stocks moved on the week's news.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Why Shares of Eli Lilly Jumped This Week
11:04am, Friday, 11'th Aug 2023
Diabetes therapy Mounjaro paced the company's revenue growth. Lilly raised full-year guidance for revenue and earnings per share.
Up 45% This Year What's Driving The Growth For Eli Lilly Stock?
09:00am, Friday, 11'th Aug 2023
The stock has been on a strong run for the last few years, primarily due to its pipeline potential.
You had to be in Eli Lilly before we got its results, not after, says Jim Cramer
07:06pm, Wednesday, 09'th Aug 2023
'Mad Money' host Jim Cramer talks investing in the current market and why it can sometimes feel like a rigged game.
3 Growth Stocks to Sell in August Before They Crash and Burn
05:51pm, Wednesday, 09'th Aug 2023
Stock markets are enduring turmoil this August. Since the beginning of the month, the benchmark S&P 500 index has declined 2%.
Eli Lilly Rises Again as Stock Upgraded Following Mounjaro Sales Surge
12:36pm, Wednesday, 09'th Aug 2023
Jefferies analyst Akash Tewari upgraded shares of Eli Lilly to Buy from Hold.
Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health data
12:19pm, Wednesday, 09'th Aug 2023
There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk's new data is a meaningful start.
Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap
11:27am, Wednesday, 09'th Aug 2023
Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs ha
